Search Results - "KENNER, L"

Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms by Unger, C, Kramer, N, Unterleuthner, D, Scherzer, M, Burian, A, Rudisch, A, Stadler, M, Schlederer, M, Lenhardt, D, Riedl, A, Walter, S, Wernitznig, A, Kenner, L, Hengstschläger, M, Schüler, J, Sommergruber, W, Dolznig, H

“…The insulin-like growth factor (IGF)2/IGF1 receptor (IGF1R) signaling axis has an important role in intestinal carcinogenesis and overexpression of IGF2 is an…”
Get full text

Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI by Papp, L., Spielvogel, C. P., Grubmüller, B., Grahovac, M., Krajnc, D., Ecsedi, B., Sareshgi, R. A.M., Mohamad, D., Hamboeck, M., Rausch, I., Mitterhauser, M., Wadsak, W., Haug, A. R., Kenner, L., Mazal, P., Susani, M., Hartenbach, S., Baltzer, P., Helbich, T. H., Kramer, G., Shariat, S.F., Beyer, T., Hartenbach, M., Hacker, M.

“…Purpose Risk classification of primary prostate cancer in clinical routine is mainly based on prostate-specific antigen (PSA) levels, Gleason scores from…”
Get full text

A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice by Radloff, J., Latic, N., Pfeiffenberger, U., Schüler, C., Tangermann, S., Kenner, L., Erben, R. G.

“…C57BL/6 mice are known to be rather resistant to the induction of experimental chronic kidney disease (CKD) by 5/6-nephrectomy (5/6-Nx). Here, we sought to…”
Get full text

Blocking antibodies induced by allergen‐specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model by Vizzardelli, C., Gindl, M., Roos, S., Möbs, C., Nagl, B., Zimmann, F., Sexl, V., Kenner, L., Neunkirchner, A., Zlabinger, G. J., Pickl, W. F., Pfützner, W., Bohle, B.

“…Background Allergen‐specific immunotherapy (AIT) induces specific blocking antibodies (Ab), which are claimed to prevent IgE‐mediated reactions to allergens…”
Get full text

JunB and PTEN in prostate cancer: ‘loss is nothing else than change’ by Birner, P, Egger, G, Merkel, O, Kenner, L

Get full text

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations by Balendran, S., Liebmann-Reindl, S., Berghoff, A. S., Reischer, T., Popitsch, N., Geier, C. B., Kenner, L., Birner, P., Streubel, B., Preusser, M.

“…Ovarian cancer represents the most common gynaecological malignancy and has the highest mortality of all female reproductive cancers. It has a rare…”
Get full text

Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin by Moti, N, Malcolm, T, Hamoudi, R, Mian, S, Garland, G, Hook, C E, Burke, G A A, Wasik, M A, Merkel, O, Kenner, L, Laurenti, E, Dick, J E, Turner, S D

“…Cancer stem cells or tumour-propagating cells (TPCs) have been identified for a number of cancers, but data pertaining to their existence in lymphoma so far…”
Get full text

Imatinib‐induced complete and long‐term sustained remission in chemotherapy‐resistant systemic ALK‐positive anaplastic large cell lymphoma by Pichler, A., Kornauth, C., Garces‐de‐los‐Fayos‐Alonso, I., Kazianka, L., Alachram, H., Zibat, A., Pemovska, T., Heller, G., Greil, R., Kenner, L., Jäger, U., Staber, P.

Get full text

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice by Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., Plutzky, J., Zeyda, M., Stulnig, T. M.

“…Aims/hypothesis Obesity is strongly associated with the development of non-alcoholic fatty liver disease (NAFLD). The cytokine osteopontin (OPN) was recently…”
Get full text

PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma by Garces de Los Fayos Alonso, I, Zujo, L, Wiest, I, Kodajova, P, Timelthaler, G, Edtmayer, S, Zrimšek, M, Kollmann, S, Giordano, C, Kothmayer, M, Neubauer, H A, Dey, S, Schlederer, M, Schmalzbauer, B S, Limberger, T, Probst, C, Pusch, O, Högler, S, Tangermann, S, Merkel, O, Schiefer, A I, Kornauth, C, Prutsch, N, Zimmerman, M, Abraham, B, Anagnostopoulos, J, Quintanilla-Martinez, L, Mathas, S, Wolf, P, Stoiber, D, Staber, P B, Egger, G, Klapper, W, Woessmann, W, Look, T A, Gunning, P, Turner, S D, Moriggl, R, Lagger, S, Kenner, L

“…Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin T cell lymphoma commonly driven by NPM-ALK. AP-1 transcription factors, cJUN and JUNb, act…”
Get full text

Postoperative radiotherapy versus surgery alone for T1N1 and T2N0 oropharygeal squamous cell carcinoma: a nationwide and retrospective study by Kadletz, L, Kenner, L, Poyntner, L, Formanek, M, Primosch, T, Schartinger, V, Brunner, M

Get full text

Jun and JunD-dependent functions in cell proliferation and stress response by Meixner, A, Karreth, F, Kenner, L, Penninger, J M, Wagner, E F

“…Jun is essential for fetal development, as fetuses lacking Jun die at mid-gestation with multiple cellular defects in liver and heart. Embryos expressing JunD…”
Get full text

Enhanced Recovery after Surgery in Gynecology: A Review of the Literature by Scheib, Stacey A., Thomassee, May, Kenner, Jamaan L.

“…Enhanced recovery after surgery (ERAS), or “fast-track” protocol, aims to minimize the physiologic stress of surgery and optimize the rehabilitation of…”
Get full text

Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria by Lim, M. S., Beyer, Thomas, Babayan, A., Bergmann, M., Brehme, M., Buyx, A., Czernin, J., Egger, G., Elenitoba-Johnson, K. S. J., Gückel, B., Jačan, A., Haslacher, H., Hicks, R. J., Kenner, L., Langanke, M., Mitterhauser, M., Pichler, B. J., Salih, H. R., Schibli, R., Schulz, S., Simecek, J., Simon, J., Soares, M. O., Stelzl, U., Wadsak, W., Zatloukal, K., Zeitlinger, M., Hacker, M.

“…Here, we report on the outcome of the 2nd International Danube Symposium on advanced biomarker development that was held in Vienna, Austria, in early 2018…”
Get full text

Stat5 gene dosage in T cells modulates CD8+ T‐cell homeostasis and attenuates contact hypersensitivity response in mice by Nivarthi, H., Prchal‐Murphy, M., Swoboda, A., Hager, M., Schlederer, M., Kenner, L., Tuckermann, J., Sexl, V., Moriggl, R., Ermakova, O.

“…Background Contact hypersensitivity assay (CHS) faithfully models human allergies. The Stat5 transcription factors are essential for both lymphocyte…”
Get full text

Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia by Merkel, O, Wacht, N, Sifft, E, Melchardt, T, Hamacher, F, Kocher, T, Denk, U, Hofbauer, J P, Egle, A, Scheideler, M, Schlederer, M, Steurer, M, Kenner, L, Greil, R

“…Chronic lymphocytic leukemia (CLL) is the most prevalent lymphoid malignancy in the elderly of the Western world. Although treatment options have improved over…”
Get full text

New perspectives in stem cell research: beyond embryonic stem cells by Leeb, C., Jurga, M., McGuckin, C., Forraz, N., Thallinger, C., Moriggl, R., Kenner, L.

“…Although stem cell research is a rather new field in modern medicine, media soon popularized it. The reason for this hype lies in the potential of stem cells…”
Get full text

Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27–28 June 2011 by Merkel, O, Kenner, L, Turner, S D

Get full text

High expression of AF1q is an adverse prognostic factor in multiple myeloma patients treated with autologous stem cell transplantation by Hagiwara, S, Schiefer, A.I, Mine, S, Kenner, L, Tse, W

Get full text

NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation by Hadzijusufovic, E., Peter, B., Herrmann, H., Rülicke, T., Cerny-Reiterer, S., Schuch, K., Kenner, L., Thaiwong, T., Yuzbasiyan-Gurkan, V., Pickl, W. F., Willmann, M., Valent, P.

“…Background Advanced mast cell (MC) disorders are characterized by uncontrolled growth of neoplastic MC in various organs, mediator‐related symptoms, and a poor…”
Get full text